This is an automatically translated article.
For people with asthma, the use of asthma prevention medication is extremely important in the treatment regimen. Azmacort medicine contains the active ingredient Triamcinolone - an active ingredient of the glycocorticoid group indicated in the prevention of asthma attacks.
1. Uses of the drug Azmacort
"What does Azmacort do?". Azmacort is prepared in the form of an inhaled aerosol, containing the active ingredient Triamcinolone Acetonide - belongs to the Glycocorticoid group. The drug is indicated for the prophylaxis of asthma attacks in patients with bronchial asthma. Triamcinolone works by blocking the release of inflammatory substances in the body. Therefore, the drug is not used in the treatment of acute asthma attacks.
2. Dosage of Azmacort
Azmacort drug belongs to the group of prescription drugs, the dose is prescribed by the treating doctor. Patients should adhere to the prescribed dose and duration of treatment. Some recommendations for Azmacort dosage are as follows:
Adults: The recommended dose is two inhalations (150mcg)/time x 3-4 times/day or four inhalations (300mcg) x 2 times/day. The maximum dose should not exceed 16 inhalations (1200mg) in adults. Doses of 12 to 16 inhalations may be considered in adults with severe asthma; Children from 6 to 12 years old: The recommended dose is 1-2 inhalations (75 - 150mcg)/time x 3 - 4 times/day or 2-4 times/inhalation (150 - 300mcg)/time x 2 times/ day. The maximum drug dose should not exceed 12 inhalations; Children under 6 years of age: There are no adequate clinical data on the safety and efficacy of Azmacort in children under 6 years of age. Note that all patients should be titrated to the lowest effective dose when asthma treatment has stabilized. The following groups of patients need to be considered for maximum effectiveness in the treatment of Azmacort Inhalation Aerosol:
Patients not receiving systemic corticosteroids: Patients on maintenance therapy of asthma with Azmacort can achieve maximum effectiveness. at the recommended dose. In drug-responsive patients, lung function improved markedly in 1-2 weeks after treatment; Patients maintaining systemic corticosteroid therapy: Clinical studies have shown that Azmacort Inhalation Aerosol is effective in patients with asthma dependent or on systemic corticosteroid therapy, allowing for a reduced dose of the drug. systemic corticosteroids. Patients should be treated to a stable stage of asthma before using Azmacort Inhalation Aerosol. In the initial period, Aerosol should be co-administered with the patient's usual systemic corticosteroids. After 1 week of treatment, the systemic corticosteroid dose should be gradually reduced by reducing the daily or alternate days. The duration of dose reduction depends on the response and condition of the patient (generally not to exceed 2.5 mg Prednisone or equivalent).
3. Side effects of Azmacort
Azmacort used to treat asthma can cause some of the following side effects:
Fatigue, loss of appetite, weight loss, nausea; Respiratory diseases such as wheezing; skin bruising, skin rash, numbness, severe tingling, numbness, pain, muscle weakness; Pain or burning when urinating; Changes in the location, shape, and distribution of body fat (especially in the legs, arms, neck, face, breasts, and waist); Symptoms are getting worse. Some less serious side effects include:
Diarrhea, nausea, upset stomach; Muscle pain, joint pain; Dry nose, mouth or throat; The appearance of sores or white patches in the mouth or on the lips; Sinus pain, stuffy nose, cough, sore throat; Low voice or hoarse voice.
4. Notes when using Azmacort
Before using Azmacort, the patient needs to inform the treating doctor if he has an infection or any kind of disease.
Azmacort is classified as group C in pregnancy. Therefore, Azmacort medicine can harm an unborn baby. Patients should inform their doctor if they are pregnant or plan to become pregnant.
For women who are breast-feeding: There are no studies to prove whether Azmacort passes into breast milk. Therefore, the drug should only be used in lactating women when the benefits outweigh the risks and should be prescribed by a doctor.
Triamcinolone affects the growth of children. Therefore, Azmacort is contraindicated in children under 5 years of age.
Prolonged corticosteroid therapy can lead to bone loss, especially in cases where the patient smokes, does not exercise, does not add calcium and vitamin D in the diet.
Patients need to rinse their mouth with physiological saline after using Azmacort to prevent the risk of developing yeast in the mouth.
Azmacort medicine contains the active ingredient Triamcinolone - an active ingredient of the glycocorticoid group indicated in the prevention of asthma attacks. To ensure the effectiveness of the treatment, the patient needs to take the medicine exactly as directed by the doctor.
5. Drug interactions
Azmacort may interact with certain medications. Drug interactions occur to reduce the therapeutic effect of the drug, increasing the risk of unwanted effects. Therefore, patients need to inform the treating doctor of all medicines they are using including prescription drugs, dietary supplements, and over-the-counter drugs before starting treatment with Azmacort.
Azmacort drug is prepared in the form of aerosol inhalation, containing the active ingredient Triamcinolone Acetonide - belongs to the Glycocorticoid group. The drug is indicated for the prophylaxis of asthma attacks in patients with bronchial asthma. To ensure the effectiveness of treatment and avoid unwanted side effects, patients need to strictly follow the instructions of the doctor, professional pharmacist.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
Reference source: drugs.com
